| Israel | Turki | Austria | |
| Rehabilitasi multiple sclerosis | dari $15,800 | dari $3,000 | dari $10,000 |
| Plasmaferesis | dari $2,200 | dari $1,200 | dari $2,000 |
| Pengobatan medikamentosa untuk multiple sclerosis | dari $15,000 | dari $2,500 | dari $2,000 |
| Ocrevus (okrelizumab) | dari $16,500 | dari $10,000 | dari $35,000 |
| Pertukaran plasma | - | dari $3,900 | - |
Kepala Pusat Neuroimunologi di Sourasky Medical Center – spesialis terkemuka Israel dalam sklerosis ganda dengan keahlian penelitian dari Harvard.
Spesialis dalam neurologi pediatrik dengan fokus pada sklerosis multipel di Sourasky Medical Center. Menggabungkan keahlian klinis dengan wawasan penelitian.
Prof. Ben-Hur memimpin Divisi Neurosains di Hadassah Medical Center, yang berspesialisasi dalam kedokteran regeneratif dan neuroimunologi.
Dr. Linecki membawa 23+ tahun pengalaman neurologi di Hadassah Medical Center, dengan spesialisasi dalam gangguan sistem saraf yang kompleks.
Israel merupakan pemimpin dalam pengobatan multiple sclerosis berkat pengembangan obat yang inovatif dan penelitian sel punca pertama di dunia. Para ilmuwan lokal mengembangkan Copaxone, obat MS terkemuka yang digunakan di seluruh dunia. Pusat-pusat khusus, seperti Hadassah Medical Center, menawarkan protokol unik untuk menyuntikkan sel punca yang berasal dari sumsum tulang langsung ke dalam cairan serebrospinal.
Pendapat ahli Bookimed: Pusat-pusat neurologi Israel menerima sejumlah besar pasien internasional, dengan Pusat Medis Hadassah saja melayani 1.000.000 pasien setiap tahunnya. Arus pasien yang besar ini memungkinkan para dokter untuk berspesialisasi dalam kasus-kasus neuroimunologi yang langka. Spesialis terkemuka, seperti Dr. Arnon Karni dari Pusat Medis Sourasky, diakui di seluruh dunia atas pengobatan penyakit autoimun yang kompleks.
Opini Pasien: Pasien mencatat bahwa protokol Israel memberikan akses ke perawatan eksperimental yang seringkali tidak tersedia di negara lain. Banyak yang menekankan bahwa, meskipun biayanya signifikan, kemampuan untuk menghentikan perkembangan penyakit melalui program perawatan sel punca yang sah dapat mengubah hidup.
Klinik-klinik di Israel menawarkan perawatan mutakhir untuk multiple sclerosis, termasuk transplantasi sel induk autologus (HSCT), injeksi sel induk intratekal, dan antibodi monoklonal yang sangat efektif. Pusat-pusat khusus, seperti Hadassah dan Sourasky, menggunakan MRI presisi tinggi dan analisis cairan serebrospinal. Protokol-protokol ini bertujuan untuk memperbaiki kerusakan neurologis dan memulihkan sistem kekebalan tubuh.
Keahlian Bookimed: Pasien yang mencari perawatan ahli di bidang neuroimunologi perlu memperhatikan bahwa Dr. Dimitrios Karoussis dan Profesor Tamir Ben-Hur dari Hadassah Medical Center berspesialisasi dalam pengobatan regeneratif. Data kami menunjukkan bahwa para dokter ini memegang posisi kepemimpinan di komite penelitian multiple sclerosis Eropa. Hal ini memastikan pasien memiliki akses ke protokol pengobatan, seringkali sebelum mereka dapat mencari pengobatan dari lembaga medis lain untuk MS.
Opini pasien: Pasien mencatat bahwa protokol transplantasi sel induk hematopoietik Israel seringkali memerlukan periode isolasi yang lebih pendek daripada di negara lain. Mereka merekomendasikan untuk merencanakan rehabilitasi pasca perawatan setidaknya selama enam bulan sebelumnya.
Opini ahli Bookimed: Meskipun banyak negara menghadapi daftar tunggu yang panjang, konsentrasi pusat spesialis yang tinggi di Israel memungkinkan diagnosis yang cepat. Di Pusat Medis Hadassah, Dr. Dimitrios Karoussis menggabungkan lebih dari 30 tahun pengalaman dengan penelitian di bidang neuroimunologi. Keahlian yang terkonsentrasi ini sering kali menghasilkan konfirmasi diagnosis dalam waktu delapan minggu, berkat rujukan dari dana kesehatan nasional.
Umpan balik pasien: Pasien melaporkan efektivitas proses ini, yang seringkali mencakup pemindaian MRI dalam waktu seminggu setelah munculnya gejala awal, seperti mati rasa. Mereka menekankan pentingnya meminta pemeriksaan lengkap sesuai dengan kriteria McDonald, terutama di rumah sakit besar dan khusus.
Para ahli Israel merekomendasikan penggabungan pengobatan obat untuk multiple sclerosis dengan intervensi spesifik, seperti diet Mediterania "hijau", olahraga air, dan ganja medis. Strategi komplementer ini bertujuan untuk meningkatkan neuroproteksi, neurorehabilitasi, dan mengurangi gejala. Terapi gerakan khusus dan terapi panas juga merupakan perawatan klinis standar.
Opini ahli Bookimed: Pusat rehabilitasi Israel seperti Lowenstein sangat memprioritaskan keselamatan, dengan mempertimbangkan iklim. Data menunjukkan bahwa program-program tersebut memprioritaskan strategi pencegahan panas, seperti penggunaan rompi pendingin sebelum berolahraga. Hal ini sangat penting, karena bahkan sedikit peningkatan suhu tubuh dapat memperburuk gejala neurologis untuk sementara waktu di iklim Mediterania Israel.
Umpan balik pasien: Pasien menekankan bahwa konsistensi dalam terapi fisik yang disesuaikan secara individual lebih penting daripada intensitasnya. Banyak yang mencatat bahwa menjadwalkan latihan pada waktu yang lebih sejuk dan menggunakan kompres es sangat penting untuk kehidupan sehari-hari.
Israel menawarkan layanan medis yang sangat mudah diakses dan harga yang kompetitif bagi pasien internasional yang mencari pengobatan untuk multiple sclerosis. Biaya pengobatan biasanya 30-50% lebih rendah daripada di Amerika Serikat. Institusi seperti Sourasky Medical Center dan Hadassah Medical Center memiliki departemen neuroimunologi khusus yang terakreditasi oleh Joint Commission International (JCI).
Opini ahli Bookimed: Pusat-pusat neurologi Israel menunjukkan tren yang kuat menuju rehabilitasi interdisipliner. Misalnya, Rumah Sakit Lowenstein khusus bergerak di bidang rehabilitasi. Sementara biaya pengobatan berbasis obat di rumah sakit besar rata-rata antara $15.000 dan $31.000, menggabungkan pengobatan dengan pusat rehabilitasi khusus dapat mengoptimalkan hasil pemulihan fungsi motorik jangka panjang untuk pasien internasional.
Umpan balik pasien: Pasien mencatat bahwa meskipun biaya yang harus dikeluarkan sendiri lebih rendah daripada di AS, perkiraan biaya yang terperinci di awal sangat penting. Banyak yang menekankan bahwa staf yang berbahasa Inggris dan pilihan konsultasi virtual secara signifikan menyederhanakan perencanaan perjalanan awal.
Stem cell therapy for progressive multiple sclerosis is available in Israel primarily through clinical trials and bone marrow transplantation protocols. Leading university hospitals offer experimental therapies like Autologous Mesenchymal Stem Cells (MSCs). These treatments aim to repair nerve tissue and stabilise disease progression through neuroimmunology-guided protocols.
Bookimed Expert Insight: While Israel is a global leader in neuroimmunology, access to experimental stem cell protocols remains strictly regulated. Data shows over 4,500 patients have sought advanced care in Israel via Bookimed. Specialists like Dr Dimitrios Karussis, with over 30 years of experience, focus on bone marrow transplantation specifically for neurological repair rather than just immune suppression. For Australians with progressive MS, the clinical focus here is often on stabilization through these high-intensity protocols.
Patient Consensus: Patients note it is vital to distinguish between medical bone marrow transplants and wellness-style stem cell clinics in Israel. They emphasize involving an Australian neurologist to review Israeli protocols, factoring in long recovery times, and budgeting for additional costs like MRI scans and extended accommodation.
Israeli hospitals confirm or review Multiple Sclerosis (MS) using a specialised diagnostic work-up. Specialists apply the international McDonald Criteria to verify central nervous system damage. This approach uses high-resolution 3T MRI scans and lumbar punctures to assess lesion distribution and identify autoimmune biomarkers.
Bookimed Expert Insight: Israeli centres such as Hadassah Medical Center function as research hubs for advanced neuroimmunology. Specialists there, including Dr Dimitrios Karussis, have 30+ years of experience and may offer stem cell-based trials. This deep research focus ensures patients receive the most accurate staging before starting therapy.
Patient Consensus: Patients note that Israeli hospitals never take outside diagnoses at face value. They recommend bringing original MRI discs and a dated symptom timeline, as specialists often adjust treatment plans after conducting their own clinical work-up in Israel.
Israel offers a comprehensive range of Multiple Sclerosis disease-modifying therapies, including oral medicines, high-efficacy infusions, and self-injectables. JCI-accredited centres like Hadassah and Sourasky utilise advanced protocols for relapsing and progressive forms. Patients can access innovative treatments like Ocrevus and stem cell therapies.
Bookimed Expert Insight: Israeli MS care is deeply rooted in local innovation. Copaxone was developed at Israel's Weizmann Institute. At Hadassah Medical Center, Dr Dimitrios Karussis brings 30+ years of experience in neuroimmunology and pioneering bone marrow transplants. This research-heavy environment means patients often access emerging protocols before they become standard elsewhere.
Patient Consensus: Patients note that Israel provides modern therapies comparable to other high-income nations. Those visiting Sourasky Medical Center for specialists like Dr Arnon Karni appreciate the sensitive attitude and detailed treatment plans, though they advise planning for long-term continuity of care with their home neurology team.
An integrated MS neuro-rehabilitation plan combines medical treatments like Ocrevus or stem cell therapy with multidisciplinary physical, cognitive, and emotional support. Integrated plans in Israel utilise neuroimmunology specialists and advanced diagnostics to customise recovery goals. These plans improve mobility while managing fatigue.
Bookimed Expert Insight: Israeli MS centres stand out by housing dedicated EAE laboratories and regenerative medicine units within the hospital. Dr Dimitrios Karussis at Hadassah Medical Center leads a multidisciplinary clinic that integrates bone marrow transplantation with standard rehabilitation. This allows patients to access experimental therapies and standard neuro-rehab through one coordinated clinical pathway.
Patient Consensus: Patients note the importance of sensitive care and detailed doctor consultations when managing multiple sclerosis. Those visiting Israel emphasise that team communication between neurologists and therapists prevents conflicting advice on activity limits.
Israeli hospitals manage acute multiple sclerosis relapses through rapid clinical protocols. Treatment typically involves 3 to 5 days of high-dose intravenous corticosteroids. Specialist centres like Sourasky Medical Center provide multidisciplinary monitoring. Advanced options like plasmapheresis or Ocrevus are available for severe cases which resist standard steroid therapy.
Bookimed Expert Insight: Israeli neurology departments operate with massive patient volumes, with Hadassah Medical Center alone serving 1,000,000 patients annually. This high throughput means specialists like Dr Dimitrios Karussis, who has 30+ years of experience, have managed thousands of acute relapses. For Australian patients, this level of clinical expertise often provides more nuanced adjustment of pulsed steroid doses than smaller, less specialised units.
Patient Consensus: Patients note that high-dose intravenous steroids are the standard rescue treatment. They suggest having a clear action plan from a neurologist like Dr Arnon Karni. In Israel, medical teams focus on severe symptoms affecting mobility or vision for hospital admission.
Israel's top national multiple sclerosis centres are primarily located in Tel Aviv, Jerusalem, and Haifa. High-profile facilities like Sourasky, Hadassah, and Rambam Medical Centres provide specialised neuroimmunology units. These centres offer advanced diagnostics, stem cell research, and multidisciplinary rehabilitation for complex neurological cases.
Bookimed Expert Insight: Israeli neurology centres such as Hadassah and Sourasky operate as large university hospitals. This connection allows patients to access experimental protocols like bone marrow transplantation earlier than elsewhere. Dr Dimitrios Karussis and Dr Tamir Ben-Hur at Hadassah specifically focus on these regenerative medicine paths for progressive cases.
Patient Consensus: Patients note the benefit of seeing neurologists like Dr Arnon Karni who provide sensitive care during complex diagnostics. In Israel, finding an integrated centre that handles MRI scans, infusion services, and long-term medication logistics in one location is highly valued.
Israel leads global Multiple Sclerosis (MS) treatment through pioneering research and JCI-accredited facilities. It offers world-first protocols including NG-01 stem cell therapy. Leading centres like Sourasky and Hadassah provide multidisciplinary neuro-rehabilitation using advanced robotic gait systems to improve patient mobility.
Bookimed Expert Insight: Israeli MS centres stand out because their neurologists are often active researchers. Dr Tamir Ben-Hur has authored over 100 research papers. This means patients access innovative therapies like nerve system regeneration before they reach Australia. The concentration of Nobel laureates at centres like Rambam ensures a high standard of clinical reasoning for complex cases.
Patient Consensus: Patients value how Israeli clinics coordinate diagnostic scans and infusion planning in one location. This makes the experience efficient for those travelling from Australia. They highlight the importance of obtaining a clear treatment plan to share with their local neurologist for long-term care.